Zinzino AB (ZZ.B) AI Stock Analysis

• Market Cap: kr4.21B
• Dividend Yield: 3.45%
• Average Volume (3M): 251.20K
• Price to Earnings (P/E): 20.6
• Beta (1Y): 0.70
• Revenue Growth: 42.95%
• EPS Growth: 6.06%
• Country: SE
• Employees: 242
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 1.49
• Shares Outstanding: 31,164,148
• 10 Day Avg. Volume: 154,528
• 30 Day Avg. Volume: 251,198
• PEG Ratio: 8.26
• Price to Book (P/B): 7.49
• Price to Sales (P/S): 1.31
• P/FCF Ratio: 9.80
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 65 Neutral
• Price Target: kr131.00 ▲(8.99% Upside)

Zinzino AB's overall stock score is primarily driven by its strong financial performance, characterized by robust revenue growth and stable profitability. However, the technical analysis indicates bearish momentum, which tempers the positive financial outlook. The valuation is reasonable, supported by a fair P/E ratio and an attractive dividend yield, but the lack of earnings call data and corporate events limits additional insights.

Zinzino AB Business Overview & Revenue Model

Company Description

Zinzino AB (ZZ.B) is a Swedish company that operates in the health and wellness sector, specializing in nutritional products and supplements. The company is known for its unique product lines, including high-quality oils, food supplements, and other health-related products designed to promote optimal health and well-being. Zinzino markets its products through a direct sales model, leveraging a network of independent distributors and influencers to reach consumers worldwide.

How the Company Makes Money

Zinzino AB generates revenue primarily through the sale of its nutritional products and supplements. The company's revenue model is built on a direct sales approach, which allows it to sell products directly to consumers via a network of independent distributors. These distributors earn commissions based on their sales, which incentivizes them to promote Zinzino's products actively. Key revenue streams include product sales from its various health and wellness lines, subscription services for regular product deliveries, and potential partnerships with wellness influencers and health professionals that help expand its market reach. Additionally, Zinzino may benefit from strategic partnerships that enhance its product offerings or distribution capabilities, contributing to overall earnings.

Zinzino AB Financial Statement Overview

Summary

Zinzino AB exhibits strong financial performance with robust revenue growth, stable profitability, and efficient cash management. The company's low leverage and high return on equity indicate financial stability and effective use of resources. While there is room for improvement in equity financing, the overall financial health is solid.

Income Statement

Zinzino AB has demonstrated strong revenue growth with a TTM increase of 11.62%, indicating robust demand for its products. The company maintains healthy profitability with a gross profit margin of 31.43% and a net profit margin of 7.13% in the TTM. While the EBIT and EBITDA margins have slightly decreased compared to previous years, they remain solid at 9.47% and 10.65%, respectively. Overall, the income statement reflects a positive growth trajectory and stable profitability.

Balance Sheet

The balance sheet of Zinzino AB shows a strong equity position with a debt-to-equity ratio of 0.12, indicating low financial leverage and reduced risk. The return on equity is impressive at 47.98%, showcasing efficient use of shareholder funds. However, the equity ratio stands at 32.39%, suggesting room for improvement in asset financing through equity. The balance sheet reflects financial stability with a focus on equity financing.

Cash Flow

Zinzino AB's cash flow statement highlights a healthy free cash flow growth of 6.49% in the TTM, supporting its operational and investment activities. The operating cash flow to net income ratio is 1.77, indicating strong cash generation relative to net income. The free cash flow to net income ratio is high at 95.88%, reflecting efficient cash management. Overall, the cash flow statement demonstrates strong cash generation and effective cash utilization.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.76B	2.21B	1.76B	1.36B	1.29B	1.07B
Gross Profit	868.61M	732.48M	645.93M	378.45M	345.39M	284.36M
EBITDA	294.39M	253.59M	245.88M	117.02M	137.95M	108.63M
Net Income	197.03M	169.17M	163.74M	67.70M	86.20M	64.48M
Balance Sheet
Total Assets	1.38B	1.21B	842.13M	651.25M	605.21M	483.39M
Cash, Cash Equivalents and Short-Term Investments	408.53M	463.05M	321.24M	161.88M	235.73M	143.22M
Total Debt	52.20M	46.06M	61.38M	49.58M	38.94M	44.13M
Total Liabilities	930.70M	818.94M	578.34M	490.88M	453.49M	388.73M
Stockholders Equity	446.15M	386.14M	259.97M	154.45M	143.05M	87.42M
Cash Flow
Free Cash Flow	334.25M	295.19M	234.36M	17.92M	143.82M	92.43M
Operating Cash Flow	348.61M	309.11M	246.14M	42.86M	153.49M	97.31M
Investing Cash Flow	-111.07M	-98.67M	-11.92M	-35.42M	-11.98M	-9.38M
Financing Cash Flow	-112.59M	-68.63M	-74.87M	-81.28M	-49.00M	-21.55M

Zinzino AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 120.20
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ZZ.B, the sentiment is Negative. The current price of 120.2 is below the 20-day moving average (MA) of 122.52, below the 50-day MA of 147.53, and below the 200-day MA of 171.65, indicating a bearish trend. The MACD of -9.15 indicates Negative momentum. The RSI at 31.43 is Neutral, neither overbought nor oversold. The STOCH value of 7.38 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:ZZ.B.

Zinzino AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CLA.B	―	kr10.29B	15.54	11.94%	3.08%	1.61%	34.76%
VIVA	―	kr3.26B	20.22	―	4.04%	8.80%	48.18%
ZZ.B	―	kr4.21B	20.55	51.17%	3.45%	42.95%	6.06%
Sector *	―	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
HUMBLE	―	€3.54B	41.17	0.87%	―	5.99%	-38.16%
MSON.B	―	kr1.20B	―	-0.17%	2.43%	-2.95%	-112.90%
DOXA	―	kr696.76M	―	-35.70%	―	-18.46%	4.90%

Zinzino AB Corporate Events

Zinzino AB Reports Strong Q2 2025 Revenue Growth

Zinzino AB, a global direct sales company based in Scandinavia, specializes in test-based, personalized dietary supplements and scientific skincare, with a presence in over 100 markets worldwide. In its latest earnings report, Zinzino AB reported a significant revenue growth of 57% for the second quarter of 2025, reaching SEK 794.4 million, compared to the same period last year. The company’s gross profit for the quarter was SEK 247.9 million, although the gross profit margin saw a slight decline to 31.2% due to increased costs related to customs, transport, and distributor remunerations. Zinzino’s strategic acquisitions, including Valentus Global and Ecosystem SAS, have bolstered its distribution capabilities in Europe and France, respectively, contributing to its robust growth. The company also successfully launched operations in China and achieved full market status in the Philippines, further expanding its global footprint. Looking ahead, Zinzino aims for an average sales growth of at least 20% annually from 2025 to 2027, with a focus on enhancing its technological platform and expanding its product offerings to sustain its growth trajectory.